Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Isoniazid | 2 | 2017 | 279 | 0.940 |
Why?
|
| Elephantiasis | 1 | 2023 | 11 | 0.900 |
Why?
|
| Tanzania | 13 | 2024 | 1407 | 0.750 |
Why?
|
| Antitubercular Agents | 3 | 2017 | 1382 | 0.660 |
Why?
|
| HIV Infections | 11 | 2024 | 17530 | 0.560 |
Why?
|
| Lymphedema | 1 | 2023 | 525 | 0.550 |
Why?
|
| Latent Tuberculosis | 2 | 2017 | 223 | 0.520 |
Why?
|
| Hepatitis B | 1 | 2021 | 708 | 0.510 |
Why?
|
| Anemia, Sickle Cell | 1 | 2021 | 1062 | 0.420 |
Why?
|
| Tuberculosis | 2 | 2017 | 2013 | 0.290 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2015 | 1899 | 0.270 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 5889 | 0.250 |
Why?
|
| Skin Diseases | 1 | 2014 | 1082 | 0.250 |
Why?
|
| Patient Compliance | 1 | 2015 | 2693 | 0.240 |
Why?
|
| Sputum | 2 | 2017 | 513 | 0.230 |
Why?
|
| Tuberculosis, Pulmonary | 3 | 2021 | 837 | 0.220 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2014 | 2184 | 0.200 |
Why?
|
| Methadone | 1 | 2024 | 318 | 0.190 |
Why?
|
| Opiate Substitution Treatment | 1 | 2024 | 452 | 0.170 |
Why?
|
| Edema | 1 | 2023 | 761 | 0.170 |
Why?
|
| Hepatitis B virus | 1 | 2021 | 530 | 0.150 |
Why?
|
| Focus Groups | 1 | 2024 | 1459 | 0.140 |
Why?
|
| Prevalence | 4 | 2023 | 15832 | 0.140 |
Why?
|
| Models, Econometric | 1 | 2017 | 214 | 0.140 |
Why?
|
| Dyslipidemias | 1 | 2023 | 869 | 0.130 |
Why?
|
| Bronchi | 1 | 2019 | 844 | 0.120 |
Why?
|
| Lower Extremity | 1 | 2023 | 1226 | 0.120 |
Why?
|
| Young Adult | 10 | 2024 | 59849 | 0.120 |
Why?
|
| Cross-Sectional Studies | 6 | 2023 | 26276 | 0.120 |
Why?
|
| Hypertension | 3 | 2024 | 8625 | 0.120 |
Why?
|
| Viral Load | 1 | 2024 | 3385 | 0.120 |
Why?
|
| Bronchoscopy | 1 | 2019 | 908 | 0.110 |
Why?
|
| Vital Capacity | 1 | 2016 | 994 | 0.110 |
Why?
|
| Qualitative Research | 1 | 2024 | 3135 | 0.100 |
Why?
|
| Forced Expiratory Volume | 1 | 2016 | 1827 | 0.090 |
Why?
|
| Obesity | 2 | 2023 | 13078 | 0.090 |
Why?
|
| Genotype | 1 | 2024 | 13023 | 0.080 |
Why?
|
| Anti-Retroviral Agents | 2 | 2021 | 1786 | 0.080 |
Why?
|
| Adult | 12 | 2024 | 223055 | 0.080 |
Why?
|
| Opioid-Related Disorders | 1 | 2024 | 2176 | 0.080 |
Why?
|
| Adolescent | 7 | 2022 | 88794 | 0.080 |
Why?
|
| Male | 11 | 2024 | 363740 | 0.070 |
Why?
|
| Anthropometry | 1 | 2011 | 1339 | 0.070 |
Why?
|
| Humans | 17 | 2024 | 765823 | 0.060 |
Why?
|
| Female | 13 | 2024 | 396050 | 0.060 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2022 | 2586 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 5529 | 0.060 |
Why?
|
| Interviews as Topic | 1 | 2011 | 2741 | 0.050 |
Why?
|
| Pyrrolidines | 1 | 2024 | 337 | 0.050 |
Why?
|
| Social Class | 1 | 2011 | 2009 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 6360 | 0.050 |
Why?
|
| Mass Screening | 1 | 2017 | 5445 | 0.050 |
Why?
|
| Quality of Life | 1 | 2023 | 13466 | 0.050 |
Why?
|
| Middle Aged | 8 | 2024 | 223016 | 0.050 |
Why?
|
| Aged | 5 | 2023 | 171178 | 0.050 |
Why?
|
| Nevirapine | 1 | 2022 | 273 | 0.040 |
Why?
|
| Polypharmacy | 1 | 2023 | 306 | 0.040 |
Why?
|
| Pneumoconiosis | 1 | 2019 | 32 | 0.040 |
Why?
|
| Risk Factors | 3 | 2023 | 74853 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2024 | 1194 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2019 | 755 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 15645 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2017 | 54798 | 0.030 |
Why?
|
| HIV | 1 | 2023 | 1585 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 13446 | 0.030 |
Why?
|
| Spirometry | 1 | 2016 | 928 | 0.030 |
Why?
|
| Pregnancy | 1 | 2014 | 30215 | 0.020 |
Why?
|
| Overweight | 1 | 2023 | 2443 | 0.020 |
Why?
|
| Health Personnel | 1 | 2024 | 3386 | 0.020 |
Why?
|
| Aspirin | 1 | 2021 | 3135 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2024 | 3229 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 4056 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2024 | 3834 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6765 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 5508 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 39226 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 10383 | 0.010 |
Why?
|
| Disease Progression | 1 | 2021 | 13613 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2022 | 81505 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2022 | 26337 | 0.010 |
Why?
|
| Age Factors | 1 | 2017 | 18380 | 0.010 |
Why?
|
| Infant | 1 | 2022 | 36375 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2022 | 42478 | 0.010 |
Why?
|
| Incidence | 1 | 2016 | 21501 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2017 | 41643 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 59506 | 0.010 |
Why?
|
| Child | 1 | 2022 | 80509 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 65223 | 0.010 |
Why?
|
Concepts
(88)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_